{"entity":{"type":"insider","cik":"0001691262","url":"/insider/0001691262","json_url":"/insider/0001691262.json","name":"Herberts Curt A. III","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":14,"first":"2017-05-15","last":"2018-04-17","span_basis":"filed_date"},"name_variants":[{"name":"Herberts Curt A. III","source":"filing","n_filings":14,"first_seen":"2017-05-15","last_seen":"2018-04-17"}],"transactions":[{"id":6759507,"accession":"0001209191-18-025170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-025170","line_url":"/filing/0001209191-18-025170#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8163.0,"shares_display":"8,163","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":163260.0,"total_display":"163,260.00","total_whole":"163,260","shares_owned_after":14625.0,"shares_owned_after_display":"14,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-13","filed_date":"2018-04-17","scope":"insider"},{"id":6903343,"accession":"0001209191-18-023597","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-023597","line_url":"/filing/0001209191-18-023597#line-3","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2278.0,"shares_display":"2,278","price_per_share":18.2984,"price_display":"18.30","price_state":"stated","total_value":41683.7552,"total_display":"41,683.76","total_whole":"41,684","shares_owned_after":14625.0,"shares_owned_after_display":"14,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-02","filed_date":"2018-04-04","scope":"insider"},{"id":6797031,"accession":"0001209191-18-016866","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-016866","line_url":"/filing/0001209191-18-016866#line-5","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":23.0574,"price_display":"23.06","price_state":"stated","total_value":345861.0,"total_display":"345,861.00","total_whole":"345,861","shares_owned_after":14625.0,"shares_owned_after_display":"14,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider"},{"id":6011731,"accession":"0001209191-18-007710","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-007710","line_url":"/filing/0001209191-18-007710#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":20.5903,"price_display":"20.59","price_state":"stated","total_value":308854.5,"total_display":"308,854.50","total_whole":"308,855","shares_owned_after":14625.0,"shares_owned_after_display":"14,625","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-05","scope":"insider"},{"id":6656841,"accession":"0001209191-18-002253","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-18-002253","line_url":"/filing/0001209191-18-002253#line-5","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8026.0,"shares_display":"8,026","price_per_share":18.05,"price_display":"18.05","price_state":"stated","total_value":144869.3,"total_display":"144,869.30","total_whole":"144,869","shares_owned_after":6250.0,"shares_owned_after_display":"6,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-04","scope":"insider"},{"id":6656836,"accession":"0001209191-18-002253","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-002253","line_url":"/filing/0001209191-18-002253#line-3","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6974.0,"shares_display":"6,974","price_per_share":16.35,"price_display":"16.35","price_state":"stated","total_value":114024.9,"total_display":"114,024.90","total_whole":"114,025","shares_owned_after":6250.0,"shares_owned_after_display":"6,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":4494702,"accession":"0001209191-17-064261","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-064261","line_url":"/filing/0001209191-17-064261#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11803.0,"shares_display":"11,803","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":212454.0,"total_display":"212,454.00","total_whole":"212,454","shares_owned_after":15833.0,"shares_owned_after_display":"15,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-04","filed_date":"2017-12-06","scope":"insider"},{"id":9270483,"accession":"0001209191-17-063686","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-063686","line_url":"/filing/0001209191-17-063686#line-2","is_derivative":false,"issuer_cik":"0001691262","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001691262","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3197.0,"shares_display":"3,197","price_per_share":16.7,"price_display":"16.70","price_state":"stated","total_value":53389.9,"total_display":"53,389.90","total_whole":"53,390","shares_owned_after":15833.0,"shares_owned_after_display":"15,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-04","scope":"insider"},{"id":4746948,"accession":"0001209191-17-063672","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-063672","line_url":"/filing/0001209191-17-063672#line-5","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3197.0,"shares_display":"3,197","price_per_share":16.7,"price_display":"16.70","price_state":"stated","total_value":53389.9,"total_display":"53,389.90","total_whole":"53,390","shares_owned_after":15833.0,"shares_owned_after_display":"15,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-04","scope":"insider"},{"id":9270484,"accession":"0001209191-17-063686","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-063686","line_url":"/filing/0001209191-17-063686#line-1","is_derivative":false,"issuer_cik":"0001691262","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001691262","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13433.0,"shares_display":"13,433","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":214928.0,"total_display":"214,928.00","total_whole":"214,928","shares_owned_after":17833.0,"shares_owned_after_display":"17,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-04","scope":"insider"},{"id":4746929,"accession":"0001209191-17-063672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-063672","line_url":"/filing/0001209191-17-063672#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13433.0,"shares_display":"13,433","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":214928.0,"total_display":"214,928.00","total_whole":"214,928","shares_owned_after":17833.0,"shares_owned_after_display":"17,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-30","filed_date":"2017-12-04","scope":"insider"},{"id":5255060,"accession":"0001209191-17-055830","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-055830","line_url":"/filing/0001209191-17-055830","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.250266666666667,"price_display":"15.25","price_state":"stated","total_value":228754.0,"total_display":"228,754.00","total_whole":"228,754","shares_owned_after":15833.0,"shares_owned_after_display":"15,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider","n_lines":3},{"id":4832827,"accession":"0001209191-17-051084","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-051084","line_url":"/filing/0001209191-17-051084","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":15833.0,"shares_owned_after_display":"15,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-01","filed_date":"2017-09-01","scope":"insider","n_lines":2},{"id":4944820,"accession":"0001209191-17-049038","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-049038","line_url":"/filing/0001209191-17-049038#line-5","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":55000.0,"total_display":"55,000.00","total_whole":"55,000","shares_owned_after":20517.0,"shares_owned_after_display":"20,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-14","filed_date":"2017-08-15","scope":"insider"},{"id":4944812,"accession":"0001209191-17-049038","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-049038","line_url":"/filing/0001209191-17-049038#line-3","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6474.0,"shares_display":"6,474","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":64740.0,"total_display":"64,740.00","total_whole":"64,740","shares_owned_after":20517.0,"shares_owned_after_display":"20,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-11","filed_date":"2017-08-15","scope":"insider"},{"id":4446977,"accession":"0001209191-17-045272","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-045272","line_url":"/filing/0001209191-17-045272","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Sr.VP & Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Sr.VP & Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr.VP & Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","total_whole":"150,000","shares_owned_after":20517.0,"shares_owned_after_display":"20,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-14","filed_date":"2017-07-14","scope":"insider","n_lines":2},{"id":5074374,"accession":"0001140361-17-023684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-023684","line_url":"/filing/0001140361-17-023684#line-1","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Senior VP & CBO)","role_mark":"O","role_mark_label":"Officer (Senior VP & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":6.8,"price_display":"6.80","price_state":"stated","total_value":13600.0,"total_display":"13,600.00","total_whole":"13,600","shares_owned_after":35345.0,"shares_owned_after_display":"35,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-01","filed_date":"2017-06-02","scope":"insider"},{"id":4172328,"accession":"0001140361-17-020870","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-020870","line_url":"/filing/0001140361-17-020870#line-2","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Senior VP & CBO)","role_mark":"O","role_mark_label":"Officer (Senior VP & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":17000.0,"total_display":"17,000.00","total_whole":"17,000","shares_owned_after":37345.0,"shares_owned_after_display":"37,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-12","filed_date":"2017-05-15","scope":"insider"},{"id":4172324,"accession":"0001140361-17-020870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-17-020870","line_url":"/filing/0001140361-17-020870#line-1","is_derivative":false,"issuer_cik":"0001001233","issuer_name":"SANGAMO THERAPEUTICS, INC","issuer_ticker":"SGMO","issuer_name_source":null,"issuer_url":"/issuer/0001001233","owner_cik":"0001691262","owner_name":"Herberts Curt A. III","owner_display_name":"Herberts Curt A. III","owner_url":"/insider/0001691262","role":"Officer (Senior VP & CBO)","role_mark":"O","role_mark_label":"Officer (Senior VP & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":639.0,"shares_display":"639","price_per_share":6.5,"price_display":"6.50","price_state":"stated","total_value":4153.5,"total_display":"4,153.50","total_whole":"4,154","shares_owned_after":39345.0,"shares_owned_after_display":"39,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-11","filed_date":"2017-05-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001001233","name":"SANGAMO THERAPEUTICS, INC","url":"/issuer/0001001233","role":"Officer (Sr.VP & Chief Business Officer)","n_filings":14,"first_seen":"2017-05-15","last_seen":"2018-04-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001691262","retrieved_at":"2026-08-24T17:47:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}